WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.11 Cr | ₹-4.86 Cr | ₹1.60 Cr | ₹3.12 Cr | ₹-15 Cr |
What is the latest Net Cash Inflow / Outflow ratio of WINDLAS BIOTECH ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹0.11 Cr |
| Mar2025 | ₹-4.86 Cr |
| Mar2024 | ₹1.60 Cr |
| Mar2023 | ₹3.12 Cr |
| Mar2022 | ₹-15 Cr |
How is Net Cash Inflow / Outflow of WINDLAS BIOTECH Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.11 Cr | Positive | |
| Mar2025 | ₹-4.86 Cr | Negative | |
| Mar2024 | ₹1.60 Cr | -48.59 | |
| Mar2023 | ₹3.12 Cr | Positive | |
| Mar2022 | ₹-15 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,058.8 Cr | 8.2% | 5.3% | 5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 8.2% |
5.3% |
5.7% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses